Safety and efficacy of inhaled interferon-β1a (SNG001) in adults with mild-to-moderate COVID-19: a randomized, controlled, phase II trial
- ACTIV-2/A5401 Study Team
- , Prasanna Jagannathan
- , Kara W. Chew
- , Mark J. Giganti
- , Michael D. Hughes
- , Carlee Moser
- , Mark J. Main
- , Phillip D. Monk
- , Arzhang Cyrus Javan
- , Jonathan Z. Li
- , Courtney V. Fletcher
- , Caitlyn McCarthy
- , David A. Wohl
- , Eric S. Daar
- , Joseph J. Eron
- , Judith S. Currier
- , Upinder Singh
- , Davey M. Smith
- , William Fischer
- , Kara Chew
Research output: Contribution to journal › Article › peer-review
11
Link opens in a new tab
Scopus
citations